HORIBA Medical is informing all PENTRA 200 and PENTRA 400 customers of a potential for reporting
incorrect calcium results when using the ABX PENTRA CALCIUM CP reagent.
Source facts
Action
Horiba Medical sent an Urgent Safety Notice dated September 6, 2013, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer.
The customer notification letter dated September 6, 2013 will be sent to all PENTRA 200 and PENTRA 400 customers of a potential for reporting incorrect calcium results when using the ABX PENTRA CALCIUM CP reagent (Reference #: A11A01633) Lot#: 014664503. The recall letter informs the customers that the initial functional tests indicate that there is no interference identified with regards to the patient results. However, with time, there may be an increase in the quantity of precipitates and this could potentially interfere with the performance of this reagent. Customers are informed of the actions to be taken and to complete the customer response form within 10 days.
Further questions please call (949) 453-0500 Ext. 208
Initiated
2013-09-06
Root cause
Under Investigation by firm
Terminated
2014-08-23
Distribution
Worldwide Distribution - USA including the country of Canada.
Recall number
Z-2280-2013
Recall status
Terminated
CDRH record ID
121755
FDA classified
2013-09-26
Recall event number
66209
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.